NanoViricides

(NYSEMKT) NNVC

Current Price$1.48

Market Cap$31.96M

Since IPO (2005)-90%

5 Year-57%

1 Year+13%

1 Month+27%

NanoViricides Financials at a Glance

Market Cap

$31.96M

Revenue (TTM)

$0.00

Net Income (TTM)

$1.99T

EPS (TTM)

$-0.44

P/E Ratio

-3.07

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$1.48

Volume

27,413

Open

$1.57

Price

$1.48

Volume

27,413

Open

$1.57

Previous Close

$1.48

Daily Range

$1.48 - $1.57

52-Week Range

$0.85 - $2.23

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$1.48

Volume

27,413

Open

$1.57

Previous Close

$1.48

Daily Range

$1.48 - $1.57

52-Week Range

$0.85 - $2.23

NNVC News

Could These 3 Biotechs Help Fight the MERS Virus?

Leo SunMay 17, 2014

5 of Last Week's Biggest Losers

Rick MunarrizFeb 16, 2014

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NanoViricides

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Anil R. Diwan, PhD

Website

www.nanoviricides.com

Headquarters

Shelton, CT 06484, US

NNVC Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-90%

Return on Capital

-0%

Return on Assets

-19%

Earnings Yield

-32.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$31.96M

Shares Outstanding

21.59M

Volume

27.41K

Avg. Volume

281.06K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.59M

EBITDA

$8.72M

Operating Cash Flow

$8.48M

Capital Expenditure

$56.96K

Free Cash Flow

$8.54M

Cash & ST Invst.

$1.56M

Total Debt

$0.00

NanoViricides Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$129.63K

N/A

Gross Margin

0.00%

N/A

Market Cap

$31.96M

N/A

Market Cap/Employee

$4.57M

N/A

Employees

N/A

Net Income

$1.99T

-89739536.2%

EBITDA

$2.03T

-100227881.8%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$3.21T

+126377176.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-19.47%

N/A

Return on Invested Capital

-0.00%

N/A

Free Cash Flow

$5.57T

-279969179.0%

Operating Cash Flow

$5.57T

-279969179.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.70-4.88%

GBIOGeneration Bio Co.

GBIOGeneration Bio Co.$5.34+0.00%

EVAXEvaxion Biotech A/S

EVAXEvaxion Biotech A/S$3.92-4.85%

JSPRJasper Therapeutics, Inc.

JSPRJasper Therapeutics, Inc.$0.85-11.36%

VRCAVerrica Pharmaceuticals Inc.

VRCAVerrica Pharmaceuticals Inc.$6.27-9.78%

QTTBQ32 Bio Inc.

QTTBQ32 Bio Inc.$6.30+0.80%

ANTXAN2 Therapeutics, Inc.

ANTXAN2 Therapeutics, Inc.$4.75+2.37%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

INTCIntel

INTCIntel$108.77-0.06%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

Questions About NNVC

What is the current price of NanoViricides?

NanoViricides is trading at $1.48 per share.

What is the 52-week range for NanoViricides?

Over the past 52 weeks, NanoViricides has traded between $0.85 and $2.23.

How much debt does NanoViricides have?

As of the most recent reporting period, NanoViricides reported total debt of N/A.

How much cash does NanoViricides have on hand?

NanoViricides reported $3.21M in cash and cash equivalents in its most recent financial results.

What is NanoViricides’s dividend yield?

NanoViricides does not currently have a dividend yield.

NanoViricides

NanoViricides Financials at a Glance

NNVC News

Could These 3 Biotechs Help Fight the MERS Virus?

5 of Last Week's Biggest Losers

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NanoViricides

NNVC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NanoViricides Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NNVC

What is the current price of NanoViricides?

What is the 52-week range for NanoViricides?

How much debt does NanoViricides have?

How much cash does NanoViricides have on hand?

What is NanoViricides’s dividend yield?

Premium Investing Services